Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!
Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment!
Dokkyo Medical University Hospital
Cutting-edge Medicine: Getting Immune Cells To Kill Immune Cells Can Actually Shrink Solid Tumours!
BEA-17 Granted Orphan Drug Designation By FDA For The Treatment Of Glioblastoma
Battle-tested, this real-world data confirms the clinical efficacy of Azulfidine!
